Morbidly obese patients remain an unsolved clinical problem,” explained co-author Gwo-Chin Lee, M.D., a hip and knee replacement surgeon at HSS. “Traditional weight loss measures have had mixed ...

A new Canadian guideline urges lifestyle interventions for obese children but also says today's new drugs might help kids ...

Pfizer is stopping development of its experimental oral GLP-1 drug for obesity, the company announced Monday, after a patient ...

Pfizer abandoned the development of danuglipron and plans to focus its efforts on GIPR candidates and other earlier obesity programs.

GLP-1s like Ozempic, as well as weight-loss surgery, are among the recommendations to treat childhood obesity in the first guideline update in Canada in almost 20 years.

In one study, once-daily danuglipron resulted in one patient who experienced drug-related elevated liver enzymes.

People taking GLP-1 drugs can decrease fat mass while minimizing muscle loss with a few key strategies that include proper supervision, and a protein-rich diet, the results of a new study suggest.

Pfizer has axed its oral GLP-1 asset danuglipron after one patient had potential drug-induced liver injury in a phase 1 trial ...

India’s weight loss category is undergoing a dynamic transformation triggered by scientific improvements, pharma innovation, ...

So we turned to an expert on the subject to address the top five concerns women have about starting GLP-1 meds like Ozempic. Here, how to outsmart common side effects and hurdles.  Meet our Ozempic ...

Preoperative GLP-1RA use was not significantly associated with an increased risk for postoperative aspiration pneumonia or acute respiratory failure.

In the long term, bariatric surgery is more cost-effective than new anti-obesity medications, research finds, triggering a ...